Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Vincent Rajkumar
Jun 23, 2024, 21:03 |
Blog
Blood Cancer Journal is among the top 3 hematology journals by impact factor
Vincent Rajkumar shared a post on X: "Just out! Blood Cancer Journal Impact Factor is…
Jun 23, 2024, 13:01 |
Blog
Naveen Pemmaraju: Intersection of Multiple Myeloma and Myeloproliferative Neoplasms
Naveen Pemmaraju shared a post on X: "Intersection of multiple myeloma and Myeloproliferative Neoplasms! Joseph…
Jun 21, 2024, 14:07 |
Insight
Manni Mohyuddin: Our paper on performance of myeloma staging systems
Manni Mohyuddin shared on X/Twitter: "Our paper on performance of myeloma staging systems just out: Thanks…
Jun 13, 2024, 06:08 |
Blog
Rahul Banerjee: So honored to have gotten Shaji Kumar’s wisdom on so many multiple myeloma questions
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared on X: "So honored to…
May 29, 2024, 15:32 |
Insight
Myeloma Paper of the Day, May 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Report of a modified Staging…
May 27, 2024, 06:35 |
Blog
Timothée Olivier: An academic study addressing a practical clinical question!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 7, 2024, 23:23 |
Blog
Naveen Pemmaraju: Delighted to spend some time intersecting MPNSM
Naveen Pemmaraju made the following post on X: "HOPLive24 HemOnc Pulse || Delighted to spend…
Apr 29, 2024, 20:19 |
Blog
Chadi Nabhan: “Unanswered Questions” in Heme Cancers
Chadi Nabhan, Medical Director of The University of Chicago Medical Center, shared a post on X:…
Apr 26, 2024, 15:15 |
Blog
Aaron Goodman: I will be hosting the myeloma session with some legends in the field
Aaron Goodman shared a post by Chadi Nabhan, Chairman of Precision Oncology Alliance, on X/Twitter:…
Apr 13, 2024, 03:43 |
Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
6
7
8
9
10
All:
96
Posts:
81 - 90
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube